全文获取类型
收费全文 | 1941篇 |
免费 | 100篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 35篇 |
妇产科学 | 7篇 |
基础医学 | 278篇 |
口腔科学 | 57篇 |
临床医学 | 108篇 |
内科学 | 523篇 |
皮肤病学 | 22篇 |
神经病学 | 159篇 |
特种医学 | 29篇 |
外科学 | 319篇 |
综合类 | 5篇 |
预防医学 | 56篇 |
眼科学 | 35篇 |
药学 | 137篇 |
中国医学 | 3篇 |
肿瘤学 | 266篇 |
出版年
2023年 | 9篇 |
2022年 | 17篇 |
2021年 | 32篇 |
2020年 | 26篇 |
2019年 | 25篇 |
2018年 | 49篇 |
2017年 | 27篇 |
2016年 | 43篇 |
2015年 | 28篇 |
2014年 | 47篇 |
2013年 | 48篇 |
2012年 | 73篇 |
2011年 | 90篇 |
2010年 | 75篇 |
2009年 | 43篇 |
2008年 | 73篇 |
2007年 | 85篇 |
2006年 | 68篇 |
2005年 | 62篇 |
2004年 | 85篇 |
2003年 | 88篇 |
2002年 | 91篇 |
2001年 | 80篇 |
2000年 | 84篇 |
1999年 | 74篇 |
1998年 | 24篇 |
1997年 | 12篇 |
1996年 | 17篇 |
1995年 | 14篇 |
1994年 | 15篇 |
1993年 | 12篇 |
1992年 | 45篇 |
1991年 | 52篇 |
1990年 | 51篇 |
1989年 | 49篇 |
1988年 | 32篇 |
1987年 | 40篇 |
1986年 | 42篇 |
1985年 | 27篇 |
1984年 | 30篇 |
1983年 | 25篇 |
1982年 | 13篇 |
1981年 | 8篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 8篇 |
1973年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有2043条查询结果,搜索用时 15 毫秒
61.
62.
63.
Tomohiko Imamura Yuji Tanaka Yumiko Ninomiya Masao Yoshinaga 《Pediatrics international》2015,57(4):716-718
Congenital junctional ectopic tachycardia is a rare tachyarrhythmia with high mortality. A pharmacological approach in early infancy is regarded as the first‐line therapeutic option. Pharmacologically, amiodarone alone or in combination with other drugs is the most commonly reported effective agent for congenital junctional ectopic tachycardia, but it has many adverse effects. Here we report the case of a 40‐day‐old infant. The clinical course suggests that combined oral flecainide and propranolol is an effective alternative therapy for early infants. Esophageal lead electrocardiography may give a clear diagnosis of junctional ectopic tachycardia. 相似文献
64.
Synthesis and characterization of cDNA encoding a cartilage-specific short collagen. 总被引:10,自引:11,他引:10 下载免费PDF全文
Y Ninomiya B R Olsen 《Proceedings of the National Academy of Sciences of the United States of America》1984,81(10):3014-3018
Hyaline cartilage contains a unique set of collagenous proteins. Type II collagen is the most abundant, constituting about 85% of the total cartilage collagen. In addition, several minor collagenous components have been described. To study the structure and developmental regulation of chondrocyte-specific collagens, we have constructed a cDNA library from embryonic chicken sternal cartilage mRNA. We report here on the isolation and characterization of a 3200 base-pair-long cDNA that codes for a collagenous polypeptide of unusual structure in that the total length of the molecule is only about half of pro alpha 1(II) collagen chains. The mRNA for this polypeptide is considerably smaller than mRNA encoding the pro alpha chains of interstitial collagens. In addition, the peptide encoded by the cDNA appears to contain at least three domains with triple-helical potential separated by short, noncollagenous peptides. Between the three collagenous domains are several cysteinyl residues. 相似文献
65.
Kataoka T Hamasaki S Ishida S Saihara K Okui H Fukudome T Shinsato T Mizoguchi E Ninomiya Y Otsuji Y Minagoe S Tei C 《The American journal of cardiology》2004,94(4):484-487
This study assessed the impact of coronary vascular adaptive remodeling and coronary vascular reactivity on myocardial ischemia in patients with hypertension and left ventricular hypertrophy. Myocardial ischemia is associated with impaired endothelium-independent vasodilation of resistance coronary arteries and increased minimal coronary resistance. These changes may occur in association with lumen reduction caused by attenuated adaptive remodeling in response to plaque accumulation. 相似文献
66.
Takenaka T Teraguchi H Yoshida A Taguchi S Ninomiya K Umekita Y Yoshida H Horinouchi M Tabata K Yonezawa S Yoshimitsu M Higuchi K Nakao S Anan R Minagoe S Tei C 《Journal of cardiology》2008,51(1):50-59
OBJECTIVES: Fabry disease is caused by deficiency of alpha-galactosidase A, and typically causes multi-organ dysfunction. Patients with manifestations limited to the heart, mainly left ventricular hypertrophy (LVH), have been reported as a disease variation. We have reported a 3% prevalence of this cardiac variant in men with LVH, which we designated 'cardiac Fabry disease'. The purposes of this study were to evaluate the terminal stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease. METHODS: We examined seven terminal stage patients with cardiac Fabry disease. During hospitalization, standard 12-lead electrocardiograms, Holter electrocardiograms, and echocardiograms were obtained. Autopsies were performed and macroscopic along with microscopic findings were evaluated. RESULTS: Six patients died of heart failure and one of ventricular fibrillation. Electrocardiograms revealed the presence of conduction abnormalities and nonsustained ventricular tachycardia. Echocardiograms and autopsy findings revealed LVH in all patients. Localized basal posterior wall thinning of the left ventricle was detected in the six patients who died of heart failure. All patients had severe left ventricular dysfunction. Histologically, myocardial cells, but not cardiac vascular endothelial cells, showed glycosphingolipid accumulation. No accumulation was observed in other organs or in systemic vascular endothelial cells. CONCLUSIONS: Severe left ventricular dysfunction with associated conduction disturbances and ventricular arrhythmias occur in patients with terminal stage cardiac Fabry disease. Furthermore, LVH is present and associated with thinning of the base of the left ventricular posterior wall. In contrast to typical Fabry disease, accumulation of glycosphingolipids was observed in myocardial cells but not in other organs. 相似文献
67.
68.
Masashi Ninomiya Yasuteru Kondo Tetsuya Niihori Takeshi Nagashima Takayuki Kogure Eiji Kakazu Osamu Kimura Yoko Aoki Yoichi Matsubara Tooru Shimosegawa 《Hepatology research》2014,44(6):678-684
Taking nucleoside/nucleotide analogs is a major antiviral therapy for chronic hepatitis B infection. The problem with this treatment is the selection for drug‐resistant mutants. Currently, identification of genotypic drug resistance is conducted by molecular cloning sequenced by the Sanger method. However, this methodology is complicated and time‐consuming. These limitations can be overcome by deep sequencing technology. Therefore, we performed sequential analysis of the frequency of drug resistance in one individual, who was treated with lamivudine on‐and‐off therapy for 2 years, by deep sequencing. The lamivudine‐resistant mutations at rtL180M and rtM204V and the entecavir‐resistant mutation at rtT184L were detected in the first subject. The lamivudine‐ and entecavir‐resistant strain was still detected in the last subject. However, in the deep sequencing analysis, rt180 of the first subject showed a mixture in 76.9% of the methionine and in 23.1% of the leucine, and rt204 also showed a mixture in 69.0% of the valine and 29.8% of the isoleucine. During the treatment, the ratio of resistant mutations increased. At rt184, the resistant variants were detectable in 58.7% of the sequence, with the replacement of leucine by the wild‐type threonine in the first subject. Gradually, entecavir‐resistant variants increased in 82.3% of the leucine in the last subject. In conclusion, we demonstrated the amino acid substitutions of the serial nucleoside/nucleotide analog resistants. We revealed that drug‐resistant mutants appear unchanged at first glance, but actually there are low‐abundant mutations that may develop drug resistance against nucleoside/nucleotide analogs through the selection of dominant mutations. 相似文献
69.
Koichi Okamoto Itasu Ninomiya Shogo Maruzen Hiroto Saito Tomoya Tsukada Jun Kinoshita Isamu Makino Keishi Nakamura Katsunobu Oyama Tomoharu Miyashita Hidehiro Tajima Hiroyuki Takamura Hirohisa Kitagawa Sachio Fushida Takashi Fujimura Tetsuo Ohta 《Esophagus》2014,11(2):89-98
Background
Tachyarrhythmia after esophagectomy is a severe complication that should not be underestimated because of its negative impact. The aims of this study were to clarify the cause and impact of postoperative tachyarrhythmia after thoracoscopic esophagectomy. Additionally, we analyzed the usefulness of landiolol administration for postoperative tachyarrhythmia.Methods
We evaluated the predictive factors for tachyarrhythmia onset after surgery and its clinical impact in 127 patients who underwent thoracoscopic esophagectomy with extended lymphadenectomy. Moreover, we analyzed the efficacy of landiolol for postoperative tachyarrhythmia.Results
Tachyarrhythmia developed in 38 of the 127 patients. Multivariate analysis showed that advanced age, heart disease, and hyperlipidemia were associated with postoperative tachyarrhythmia. Hyponatremia, hypoalbuminemia, and leukocytosis on postoperative day 3 were significantly associated with tachyarrhythmia onset. The incidence of all complications and respiratory complications, including pneumonia, was significantly higher in patients with than in those without tachyarrhythmia. The mortality rate in the tachyarrhythmia group tended to be higher than that in the nontachyarrhythmia group. Landiolol as a treatment for tachyarrhythmia immediately decreased heart rate and safely reduced subsequent respiratory complications.Conclusion
In elderly patients with cardiac disease or hyperlipidemia, surgeons should be alert for the occurrence of tachyarrhythmia after esophagectomy. Postoperative tachyarrhythmia is a marker of morbidities with particular emphasis on respiratory complications. However, it can be adequately managed by landiolol, resulting in fewer respiratory complications. Landiolol might be a safe and convenient agent for managing postoperative tachyarrhythmia after thoracoscopic esophagectomy, resulting in lower mortality and morbidity rates. 相似文献70.
Miku Nakagawa Riko Kitazawa Takeshi Kondo Kosuke Ninomiya Masayoshi Okita Ryuma Haraguchi Sohei Kitazawa 《Virchows Archiv : an international journal of pathology》2014,464(3):253-256
Duodenal gastric heterotopia (DGH) is a benign asymptomatic condition assumed to be of congenital origin. Since DGH is often associated with fundic gland polyps (FGPs) that frequently carry a somatic β-catenin gene mutation, we examined whether DGH, either sporadic or FGP-associated, is attributable to alterations of the Wnt/β-catenin pathway. Genetic analysis revealed frequent somatic β-catenin gene mutations in DGH; some of which showed the same mutation pattern as coexisting FGPs. All missense mutations were confined to codons 32, 33, and 37. No such mutations were observed, however, in any of the specimens from focal gastric foveolar metaplasia (GFM). Therefore, DGH is not a mere congenital lesion due to aberrant migration of normal gastric mucosa or a simple reactive metaplasia after regenerative stimuli of the duodenal mucosa, but a distinct condition based upon molecular genetic changes in the Wnt/β-catenin pathway. 相似文献